Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is a clinical research site located in Torrance, California, United States 90502.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has participated in 73 clinical trials with 51 currently active.
Therapeutic areas: Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma.
Sponsors: National Cancer Institute (NCI), Children's Oncology Group, Eli Lilly and Company.
Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center has 73 clinical trials on record, with 51 currently active. Their work covers Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma.
Yes — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.